Diagnosis and Treatment of Macrocytic Anemia

Understanding the Condition

The American College of Physicians recommends checking vitamin B12 and folate levels, and treating the identified deficiency urgently, particularly B12 deficiency, which requires immediate treatment before any folate supplementation to prevent irreversible neurological damage, in patients with low hemoglobin, high MCV, and high MCH 1
Macrocytic anemia is characterized by elevated MCV with low hemoglobin, indicating larger-than-normal red blood cells with increased hemoglobin content per cell, which is different from iron deficiency anemia that presents with low MCV and low MCH 2
Iron deficiency anemia presents with low MCV and low MCH, which is distinct from macrocytic anemia 3, 4

The American Society of Hematology recommends checking vitamin B12 level, as it is the most common cause of megaloblastic macrocytic anemia, and folate level, as it is the second most common cause of megaloblastic anemia, immediately in patients with macrocytic anemia 1
The European Hematology Association suggests assessing bone marrow response by checking reticulocyte count in patients with macrocytic anemia 2
Medication review is necessary, as anticonvulsants, methotrexate, and chemotherapeutic agents can cause macrocytosis, according to the National Comprehensive Cancer Network 2

The American College of Physicians recommends treating vitamin B12 deficiency immediately, with hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, and then maintenance with 1 mg IM every 2 months for life, in patients with neurological symptoms 1
In patients without neurological symptoms, the American College of Physicians suggests treating vitamin B12 deficiency with hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, and then maintenance with 1 mg IM every 2-3 months for life 1
The American Society of Hematology recommends treating folate deficiency with oral folic acid 5 mg daily for a minimum of 4 months, but only after excluding or treating B12 deficiency first, to prevent masking severe B12 depletion and allowing neurological damage to progress 1

Serial monitoring of red cell indices helps assess treatment response, according to the International Society for Laboratory Hematology 2
Consider bone marrow examination if the cause remains unclear after initial workup, particularly if hematological malignancy is suspected, as recommended by the European Hematology Association 2